Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer
Author:
Affiliation:
1. a University of Chicago, Chicago, Illinois, USA
2. b Friends of Cancer Research, McClean, Virginia, USA
3. c Engelberg Center for Healthcare Reform at Brookings Institution, Washington, DC, USA
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2010-0079
Reference6 articles.
1. Blinded independent central review of the progression-free survival endpoint;Amit;The Oncologist,2010
2. Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032 (abstract 6LB);Chapman;Eur J Cancer Suppl,2009
3. EGFR mutation and resistance of non small cell lung cancer to gefitinib;Kobayashi;New Engl J Med,2005
4. Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non small cell lung cancer;Engelman;Clin Cancer Res,2008
5. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling;Engelman;Science,2007
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells;Cancers;2024-07-07
2. Large-scale Prediction of Drug-Protein Interactions Based on Network Information;Current Computer-Aided Drug Design;2022-02
3. Introduction: Cancer a Global Challenge and Role of Angiogenesis in Cancer;Nanoparticles in Angiogenesis and Cancer;2022
4. Engineering and emerging applications of artificial metalloenzymes with whole cells;Nature Catalysis;2021-10
5. Molecular targeted therapy: Treating cancer with specificity;European Journal of Pharmacology;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3